8-K: Performant Healthcare to be Acquired by Machinify in $670 Million Deal

Performant Healthcare, Inc. has entered into a definitive merger agreement to be acquired by Machinify, a New Mountain Capital portfolio company, for $7.75 per share in cash, representing a 139% premium.

Summary

• Performant Healthcare, Inc. (PHLT) will be acquired by Continental Buyer, Inc. (Machinify), a portfolio company of investment funds managed by New Mountain Capital L.L.C.
• Each share of Performant common stock outstanding will be converted into the right to receive $7.75 in cash, without interest, at the effective time of the merger.
• The total transaction value is approximately $670 million.
• The per share price of $7.75 represents a premium of approximately 139% to Performant's 90-day volume weighted average price (VWAP) of $3.25 per share as of market close on July 31, 2025.
• Performant's Board of Directors unanimously approved the Merger Agreement and the contemplated transactions.
• Outstanding Company Stock Options, Restricted Stock Units (RSUs), and Performance Restricted Stock Units (PRSUs) will be canceled and converted into a lump sum cash payment based on the Merger Consideration, with PRSUs deemed to have satisfied performance conditions at 100% of target.
• The merger is subject to customary closing conditions, including adoption of the Merger Agreement by Performant stockholders and receipt of all required antitrust approvals.
• The Merger Agreement includes termination rights for both parties, with a potential termination fee of $19,980,000 payable by Performant under certain circumstances (e.g., a Company Adverse Recommendation Change or entry into a Superior Proposal).
• Performant may also be required to reimburse Parent for certain transaction expenses up to $3,000,000 in specific termination scenarios.
• Parent is required to pay a termination fee of $39,960,000 to Performant under certain conditions, such as Parent's breach or failure to close due to antitrust issues.
• Certain employees, including CEO Simeon Kohl and CFO Rohit Ramchandani, were awarded success bonuses contingent upon the consummation of the Change in Control.
• The transaction is expected to close by the end of 2025, after which Performant's shares will be delisted from Nasdaq.

Sentiment

Score: 9

Explanation: The filing announces a definitive merger agreement at a substantial premium (139% over 90-day VWAP), which is highly positive for shareholders. The unanimous board approval and strategic rationale for combining with Machinify suggest a strong, well-considered transaction. While standard merger-related risks are present, the immediate and significant financial benefit to shareholders is the dominant factor.

Positives

• Shareholders will receive a significant cash premium of approximately 139% over the 90-day volume weighted average price, providing substantial immediate value.
• The transaction received unanimous approval from Performant's Board of Directors, indicating strong internal support and belief in the deal's benefits.
• The merger creates a combined entity focused on building a modern healthcare payments intelligence platform, leveraging Performant's domain expertise and data assets with Machinify's AI-powered system.
• The acquisition aligns with New Mountain Capital's investment thesis of reducing administrative inefficiencies through technology and unlocking data value, suggesting a strategic fit and potential for future growth within the healthcare sector.

Negatives

• The proposed transaction may disrupt Performant's current plans and operations during the pendency period.
• Management's attention may be diverted from ongoing business operations due to the merger process.
• There is a risk of unexpected costs, charges, or expenses resulting from the proposed merger.
• Potential litigation relating to the merger could be instituted against the parties or their directors, managers, or officers.
• Certain restrictions during the pendency of the merger may impact Performant's ability to pursue specific business opportunities or strategic transactions.

Risks

• The proposed merger may not be completed in a timely manner or at all, which could adversely affect Performant's business and the price of its common stock.
• Failure to satisfy any of the conditions to the consummation of the proposed merger, including the receipt of certain regulatory approvals.
• Failure to obtain stockholder approval.
• The occurrence of any fact, event, change, development, or circumstance that could give rise to the termination of the merger agreement, including in circumstances requiring Performant to pay a termination fee.
• The effect of the announcement or pendency of the proposed transaction on Performant's business relationships, operating results, and business generally.
• Risks that the proposed transaction disrupts Performant's current plans and operations.
• Performant's ability to retain and hire key personnel and maintain relationships with key business partners and customers, and others with whom it does business, in light of the proposed transaction.
• Risks related to diverting management's attention from Performant's ongoing business operations.
• Unexpected costs, charges, or expenses resulting from the proposed merger.
• Potential litigation relating to the merger that could be instituted against the parties to the merger agreement or their respective directors, managers, or officers, including the effects of any outcomes related thereto.
• Certain restrictions during the pendency of the Merger that may impact Performant's ability to pursue certain business opportunities or strategic transactions.
• Uncertainty as to timing of completion of the proposed Merger.
• Legislative, regulatory, and economic developments affecting Performant's business.

Future Outlook

The combined entity aims to create a modern healthcare payments intelligence platform, built for accuracy and transparency. By integrating Machinify's Payer Operating System with Performant's domain expertise and data assets, the new company expects to support a broader range of clients, including government entities like the Centers for Medicare and Medicaid, and state and local governments. The goal is to deliver quality, timely payments at dramatically reduced administrative costs. New Mountain Capital's investment strategy emphasizes reducing administrative inefficiencies through technology and leveraging data, aligning with the broader need for modernization in U.S. healthcare IT infrastructure to achieve more efficient and patient-centric care models.

Management Comments

• Simeon Kohl, CEO of Performant, stated, "What began as a focused effort to solve complex payment integrity challenges has grown into a market-leading solution for healthcare payers. This success is a direct result of our team's dedication, and I am incredibly proud of the value we have delivered to both our clients and stockholders. After a comprehensive review of strategic alternatives, including continuing to operate as a standalone entity, our board of directors and executive leadership team unanimously concluded that this path represents the best outcome for our stockholders, clients, and employees. Machinify's aligned values, proven industry expertise, and commitment to advancing innovation will accelerate our mission and amplify our impact across the healthcare landscape."
• David Pierre, CEO of Machinify, commented, "At Machinify, we are creating the modern, healthcare payments intelligence platform built for accuracy and transparency. By combining our powerful Payer Operating System with Performant's trusted domain expertise and differentiated data assets, Machinify will support a broader range of clients, including the Centers for Medicare and Medicaid, and state and local governments. The combined company will deliver quality, timely payments at dramatically reduced administrative costs."
• Matt Holt, Managing Director and President of Private Equity at New Mountain Capital, remarked, "Our thesis for the acquisition of Performant is consistent with our prior investments, with a primary focus on reducing administrative inefficiencies through investments in technology, unlocking the value of data. The future of the U.S. healthcare system requires modernization of IT infrastructure, including patient-centric data networks. Performant plus Machinify plus the ecosystem of companies that we are building at New Mountain Capital will unlock the potential for a new system that is aligned with a more productive care model that is both more efficient and delivers better patient outcomes."

Industry Context

The acquisition of Performant by Machinify, backed by New Mountain Capital, reflects a significant trend in the healthcare industry towards leveraging technology and data to enhance payment integrity and reduce administrative inefficiencies. As the U.S. healthcare system continues to evolve, there is a growing demand for modernized IT infrastructure and patient-centric data networks. This merger aims to address these needs by combining Performant's established expertise in payment integrity and analytics with Machinify's advanced AI-powered platform, positioning the combined entity to offer more comprehensive and efficient solutions to healthcare payers, including large governmental programs.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to benchmark Performant's or the combined entity's performance against industry standards.
• Machinify's platform is noted as being deployed by over 60 health plans, including many of the top 20, and representing more than 160 million lives, indicating a significant market presence for Machinify within the healthcare intelligence sector.

Management Changes

Corporate Governance

Legal Proceedings

• The filing notes the potential for litigation relating to the merger that could be instituted against the parties to the merger agreement or their respective directors, managers, or officers.
• Performant is obligated to provide Parent with prompt notice of any stockholder litigation related to the Agreement or Transactions, allow Parent to review and comment on filings, and participate in the defense, settlement, or compromise of such proceedings.

Related Party Transactions

• The Company represents that neither it nor its Subsidiaries have been a party to any material related party transactions (as defined by Item 404 of Regulation S-K) since January 1, 2023, nor are any currently proposed, involving executive officers, senior managers, directors, or beneficial owners of 5% or more of equity, or their affiliates/family members.

Stakeholder Impact

• Shareholders: Will receive a significant cash premium for their shares, providing a substantial return on investment.
• Employees: Company Continuing Employees will receive base pay/wage rates and annual target cash incentive bonus opportunities no less favorable for 12 months post-merger. They will also receive service credit for eligibility and vesting in Parent Benefit Plans, and severance benefits if terminated under certain conditions during the continuation period. Success bonuses are specifically noted for the CEO and CFO.
• Customers/Clients: The combined entity aims to support a broader range of clients, including government entities, and deliver improved services with reduced administrative costs.
• Business Partners/Suppliers: There is a risk that the announcement or pendency of the transaction could disrupt existing business relationships.

Next Steps

• Performant will prepare and file a proxy statement with the SEC.
• Performant stockholders will hold a special meeting to vote on the adoption of the Merger Agreement and approval of the transactions.
• All required filings under applicable Antitrust Laws must be made, and necessary approvals obtained or waiting periods expired/terminated.
• The transaction is expected to close by the end of 2025.
• Following the closing of the transaction, Performant's shares will be delisted from Nasdaq.

Key Dates

Recommendation

The acquisition offers a substantial 139% premium over the recent 90-day volume weighted average price, providing immediate and significant value to shareholders. The unanimous board approval signals strong internal support for the transaction. While standard merger risks exist, the clear cash offer and the strategic rationale for combining with Machinify, backed by New Mountain Capital, make this a compelling opportunity for investors seeking a quick, high-return exit.

Keywords

Healthcare, Payment Integrity, Analytics, Merger, Acquisition, Technology, SEC Filing, PHLT, Machinify, New Mountain Capital, Private Equity, Healthcare IT, Corporate Governance, Risk Management